» Articles » PMID: 6159410

Selective Effects of Cyclosporin A on Functional B Cell Subsets in the Mouse

Overview
Journal J Immunol
Date 1980 Dec 1
PMID 6159410
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclosporin A, an immunosuppressive peptide of fungal origin, was believed to selectively affect T lymphocyte functions and to have minimal affects on B lymphocytes. This study shows that, in the mouse, T-dependent B cells and those responding to certain T-independent antigens (so-called TI-1 antigens) are indeed resistant to the drug. However, B cells responsive to other TI antigens (TI-2) are exquisitely sensitive. Thus, doses of the drug that completely abrogate responses to dinitrophenylated (DNP) Ficoll or dextran enhance the response to DNP-lipopolysaccharide and have minimal effects on the response to DNP-Brucella abortus. Virgin T helper cells are sensitive to the drug, whereas primed T cells are not. Cyclosporin A sensitivity therefore represents a novel marker of functional B cell subsets in the mouse and presumably points to fundamental physiologic differences between such subsets.

Citing Articles

Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence.

Miller C, Powers J, Musselman E, Mackie R, Elder J, VandeWoude S Viruses. 2019; 11(9).

PMID: 31480322 PMC: 6783960. DOI: 10.3390/v11090805.


Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model.

Wang J, Wang B, Huang S, Song Z, Wu J, Zhang E PLoS One. 2014; 9(1):e85832.

PMID: 24465734 PMC: 3897536. DOI: 10.1371/journal.pone.0085832.


Lymphocyte subset populations in children with polysaccharide antibody deficiency following cardiac transplantation.

Gennery A, Barge D, Spickett G, Cant A J Clin Immunol. 2001; 21(1):37-42.

PMID: 11321237 DOI: 10.1023/a:1006741015452.


Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production.

Haynes D, Gadd S, Whitehouse M, Mayrhofer G, Vernon-Roberts B Inflamm Res. 1996; 45(4):159-65.

PMID: 8741004 DOI: 10.1007/BF02285155.


Cyclosporin A. Clinical pharmacology and therapeutic potential.

White D Drugs. 1982; 24(4):322-34.

PMID: 6754333 DOI: 10.2165/00003495-198224040-00004.